KaiWei JianPI Ointment Downregulates Fcgbp and Modulates HMGB1/TLR4 Signaling to Combat Ferroptosis in H. pylori Infection
Canadian Journal of Infectious Diseases and Medical Microbiology · 2026-01 · 2026 (1)
DOI: 10.1155/cjid/4297059 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Infectious Diseases and Medical Microbiology, online erschienen am 18.04.2026. Verfasst von Xiaoying Zhu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Shenzhen Clinical College of Integrated Chinese and Western Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China, gzucm.edu.cn. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Traditional Chinese Medicine Bureau of Guangdong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
This study aimed to explore the therapeutic mechanisms of KaiWei JianPI Ointment in treating H. pylori infection, focusing on its role in regulating ferroptosis and the associated HMGB1/TLR4 signaling pathway.
Methods
We used a combination of network pharmacology, molecular docking, transcriptome sequencing, and molecular biology in this study. Active components of the KaiWei JianPI Ointments were identified using the Traditional Chinese Medicine Systems Pharmacology database. Post‐treatment transcriptomic changes in rat gastric tissues were analyzed to identify differentially expressed genes.
Results
Network analysis identified 152 active components targeting key proteins involved in immune responses and cellular signaling. Transcriptome sequencing revealed 76 differentially expressed genes linked to immune response pathways. Additionally, treatment with the KaiWei JianPI Ointment resulted in decreased levels of Fe 2+ and MDA in H. pylori ‐infected rats, suggesting inhibition of ferroptosis. This effect correlated with the downregulation of Fcgbp and modulation of HMGB1/TLR4 signaling.
Conclusions
KaiWei JianPI Ointment shows potential as a novel therapeutic strategy against H. pylori infection by inhibiting ferroptosis through modulation of the HMGB1/TLR4 pathway. This study provides insights into the application of traditional Chinese medicine in modern treatment frameworks, highlighting the need for clinical validation and further exploration of the underlying mechanisms.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Shenzhen Clinical College of Integrated Chinese and Western Medicine, Guangzhou University of Chinese Medicine, Guangzhou, China, gzucm.edu.cn.
- Gastroenterology Department, Shenzhen Hospital of Integrated Traditional Chinese and Western Medicine, Shenzhen, China.
- Guangdong Key Laboratory for Research and Development of Natural Drugs, Guangdong Medical University, Dongguan, China, gdmu.edu.cn.
ORCID-Profile: Xiaoying Zhu, Caiqun Bie
Förderung
- Traditional Chinese Medicine Bureau of Guangdong Province
- National Natural Science Foundation of China
Zitieren
APA
Zhu, X., Liu, J., Chen, M., Jin, Y., Dang, Y., Qin, X., Tang, H., & Bie, C. (2026). KaiWei JianPI Ointment Downregulates Fcgbp and Modulates HMGB1/TLR4 Signaling to Combat Ferroptosis in H. pylori Infection. Canadian Journal of Infectious Diseases and Medical Microbiology, 2026(1). https://doi.org/10.1155/cjid/4297059
Vancouver
Zhu X, Liu J, Chen M, Jin Y, Dang Y, Qin X, et al. KaiWei JianPI Ointment Downregulates Fcgbp and Modulates HMGB1/TLR4 Signaling to Combat Ferroptosis in H. pylori Infection. Canadian Journal of Infectious Diseases and Medical Microbiology. 2026;2026(1). doi:10.1155/cjid/4297059
BibTeX
@article{Zhu2026,
author = {Zhu, Xiaoying and Liu, Jie and Chen, Meng and Jin, Yubo and Dang, Yan and Qin, Xianfeng and Tang, Huijun and Bie, Caiqun},
title = {KaiWei JianPI Ointment Downregulates Fcgbp and Modulates HMGB1/TLR4 Signaling to Combat Ferroptosis in H. pylori Infection},
journal = {Canadian Journal of Infectious Diseases and Medical Microbiology},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/cjid/4297059}
}
EUVIMED